Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department
NCT: NCT06899776 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this proposal is to improve the quality and value of care for patients with acute chest pain by investigating the potential impact of point-of-care (POC) high sensitivity cardiac troponin (hs-cTn) testing in the Emergency Department (ED) and exploring how best to integrate POC hs-cTnl into ED risk stratification workflows. The study hypothesizes that the Abbott i-STAT POC hs-cTnI assay will decrease time-to-result (TTR) and ED length of stay (LOS), while increasing ED revenue for patients with acute chest pain compared to a strategy of central laboratory hs-cTnI testing.
Frequently Asked Questions
What is Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department?
Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department is a clinical trial registered under NCT06899776. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06899776?
The current status of NCT06899776 (Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department) is: ACTIVE_NOT_RECRUITING.
When did Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department start?
Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department started on 2025-02-07.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.